Yuri Sokolov, PhD, MBA
Vivosonic Inc, Toronto, reports that Yuri Sokolov, PhD, MBA, has resigned as the company’s president and chief executive officer–effective immediately.
Sokolov, who founded the Toronto-based company in 1999, became CEO and
oversaw the development of the Integrity, Vivosonic’s flagship product, and a soon-to-be-released second product.
"Yuri’s contributions to not only Vivosonic, but to patient-centric hearing health care, have been tremendous, and we thank him for his dedication and tenure," said Dr. Gerald Heffernan, chair of the board. "I am confident that the management team Yuri has built will continue to bring innovative solutions to the medical device market."
Doug Brown, VP
Doug Brown, VP of finance and operations, has assumed the role of interim general manager.
In a statement released by the company, Sokolov said that "although the time has come for me to close this chapter in my life, I eagerly look forward to the next one, for both myself and Vivosonic. I am absolutely confident Vivosonic will continue to be successful in the future."
Sokolov is a researcher, educator, and entrepreneur with more than three decades of experience in the hearing care industry.
After having established a career in the Ukraine in hearing research and clinical practice, Dr Hans Kunov and Professor Poul Madsen invited him become part of the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, according to the company’s Web site. During his tenure, Sokolov was named the first GR Hefernan co-steel innovation scholar and co-developed Vivography, a patented method for analyzing physiological signals, which is faster and more accurate than its predecessors, it says.
In 1999, Vivosonic was formed out of a desire to commercialize this technology, according to the site. The company manufactures and distributes medical devices featuring patented technologies.